Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,506.0
₹65,832 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹29,053.5
₹61,737 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,865.2
₹35,790 Cr
Pharmaceuticals & Drugs
₹1,084.3
₹21,312 Cr
Pharmaceuticals & Drugs
₹632.9
₹5,735 Cr
Pharmaceuticals & Drugs
₹377.0
₹4,217 Cr
Pharmaceuticals & Drugs
₹455.3
₹4,155 Cr
Pharmaceuticals & Drugs
₹137.5
₹3,529 Cr
Pharmaceuticals & Drugs
₹1,370.5
₹782 Cr
Pharmaceuticals & Drugs
₹61.2
₹173 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,506.0
₹12,706 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,084.3
₹6,357 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,865.2
₹4,491 Cr
Pharmaceuticals & Drugs
₹455.3
₹2,380 Cr
Pharmaceuticals & Drugs
₹632.9
₹1,968 Cr
Pharmaceuticals & Drugs
₹377.0
₹619 Cr
Pharmaceuticals & Drugs
₹137.5
₹192 Cr
Pharmaceuticals & Drugs
₹29,053.5
₹6,066 Cr
Pharmaceuticals & Drugs
₹1,370.5
₹365 Cr
Pharmaceuticals & Drugs
₹61.2
₹519 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,506.0
₹2,161 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,865.2
₹875 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,084.3
₹646 Cr
Pharmaceuticals & Drugs
₹632.9
₹228 Cr
Pharmaceuticals & Drugs
₹455.3
₹152 Cr
Pharmaceuticals & Drugs
₹377.0
₹141 Cr
Pharmaceuticals & Drugs
₹137.5
₹126 Cr
Pharmaceuticals & Drugs
₹29,053.5
₹1,285 Cr
Pharmaceuticals & Drugs
₹1,370.5
₹69 Cr
Pharmaceuticals & Drugs
₹61.2
₹7 Cr

You may also like the below Video Courses